MAPK1 and breast cancer: In summary, the combination of curcumin and MMC 1.5 mg/kg can synergistically inhibit tumor growth in MCF-7 breast cancer xenografts and induce apoptosis in breast cancer MCF-7 cells through ERK pathway.